White matter structural integrity in healthy aging adults and patients with Alzheimer disease: A magnetic resonance imaging study

Archives of Neurology

Volumn 60, Issue 3, 2003, Pages 393-398

  Bartzokis, George ^a,b,c   Cummings, Jeffrey L ^a,b   Sultzer, David ^c   Henderson, Victor W ^d   Nuechterlein, Keith H ^b   Mintz, Jim ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN MATURATION; BRAIN SIZE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FRONTAL LOBE; HUMAN; IMAGING SYSTEM; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT; PRIORITY JOURNAL; RELAXATION TIME; UNIVERSITY HOSPITAL; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; REGRESSION ANALYSIS;

EID: 0037337293     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.3.393     Document Type: Article

References (77)

1. Valk J, van der Knaap MS. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. New York, NY: Springer-Verlag NY Inc; 1989.
2. Bartzokis G, Mintz J, Marx P, et al. Reliability of in vivo volume measures of hippocampus and other brain structures using MRI. Magn Reson Imaging. 1993;11:993-1006.
3. Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry. 2001;58:461-465.
4. Yakovlev PI, Lecours AR. The myelogenetic cycles of regional maturation of the brain. In: Minkowski A, ed. Regional Development of the Brain in Early Life. Boston, Mass: Blackwell Scientific Publications; 1967:3-70.
5. Kemper TL. Neuroanatomical and neuropathological changes during aging and dementia. In: Albert ML, Knoefel JE, eds. Clinical Neurology of Aging, 2nd ed. New York, NY: Oxford University Press Inc; 1994:3-67.
6. Hildebrand C, Remahl S, Persson H, Bjartmar C. Myelinated nerve fibres in the CNS. Prog Neurobiol. 1993;40:319-384.
7. Nieuwenhuys R. Structure and organization of fibre systems. In: Nieuwenbuys R, Tendokelaar HJ, Nicholson C, eds. The Central Nervous System of Vertebrates. Vol 1. Berlin, Germany: Springer; 1999:113-157.
8. Juurlink BH. Response of glial cells to ischemia: roles of reactive oxygen species and glutathione. Neurosci Biobehav Rev. 1997;21:151-166.
9. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652-659.
10. Kurumatani T, Kudo T, Ikura Y, Takeda M. White matter changes in the gerbil brain under chronic cerebral hypoperfusion. Stroke. 1998;29:1058-1062.
11. Petty MA, Wettstein JG. White matter ischaemia. Brain Res. 1999;31:58-64.
12. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol. 1993;151:2132-2141.
13. Mitrovic B, Ignarro LJ, Vinters HV, et al. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience. 1995;65:531-539.
14. Sloane JA, Hollander W, Moss MB, Rosene DL, Abraham CR. Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol Aging. 1999;20:395-405.
15. Matute C, Sánchez-Gómez MV, Martinez-Millán L, Miledi R. Glutamate receptormediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci U S A. 1997;94:8830-8835.
16. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med. 1998;4:291-297.
17. Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia. 2000;31:219-231.
18. Ferrie JC, Barantin L, Saliba E, et al. MR assessment of the brain maturation during the perinatal period: quantitative T2 MR study in premature newborns. Magn Reson Imaging. 1999;17:1275-1288.
19. Paus T, Collins DL, Evans AC, Leonard G, Pike B, Zijdenbos A. Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res Bull. 2001;54:255-266.
20. Fazekas F, Schmidt R, Scheltens P. Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord. 1998;9(suppl 1):2-5.
21. Takao M, Koto A, Tanahashi N, Fukuuchi Y, Takagi M, Morinaga S. Pathologic findings of silent hyperintense white matter lesions on MRI. J Neurol Sci. 1999;167:127-131.
22. Oldendorf, W, Oldendorf W Jr. Basics of Magnetic Resonance Imaging. Boston, Mass: Martinus Nijhof Publishing; 1988:47.
23. Ono J, Kodaka R, Imai K, et al. Evaluation of myelination by means of the T2 value on magnetic resonance imaging. Brain Dev. 1993;15:433-438.
24. Bartzokis G, Mintz J, Sultzer D, et al. In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol. 1994;15:1129-1138.
25. Miot E, Hoffschir D, Poncy JL, Masse R, Le Pape A, Akoka S. Magnetic resonance imaging in vivo monitoring of T2 relaxation time: quantitative assessment of primate brain maturation. J Med Primatol. 1995;24:87-93.
26. Peters A, Moss MB, Sethares C. Effects of aging on myelinated nerve fibers in monkey primary visual cortex. J Comp Neurol. 2000;419:364-376.
27. Nielsen K, Peters A. The effects of aging on the frequency of nerve fibers in rhesus monkey striate cortex. Neurobiol Aging. 2000;21:621-628.
28. Terry RD, Gonatas NK, Weiss M. Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol. 1964;44:269-281.
29. Englund E, Brun A, Persson B. Correlations between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer Dis Assoc Disord. 1987;1:156-170.
30. Kamman RL, Go KG, Brouwer W, Berendsen HJ. Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature. Magn Reson Med. 1988;6:265-274.
31. Bartzokis G, Sultzer D, Mintz J, et al. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. Biol Psychiatry. 1994;35:480-487.
32. Bartzokis G, Sultzer D, Cummings J, et al. In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry. 2000;57:47-53.
33. Bondareff W, Raval J, Colletti PM, Hauser DL. Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer's disease. Am J Psychiatry. 1988;145:853-856.
34. Besson JA, Crawford JR, Parker DM, et al. Multimodal imaging in Alzheimer's disease: the relationship between MRI, SPECT, cognitive and pathological changes. Br J Psychiatry. 1990;157:216-220.
35. Erkinjuntti T, Benavente O, Eliasziw M, et al. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol. 1996;53:325-332.
36. Hanyu H, Shindo H, Kakizaki D, Abe K, Iwamoto T, Takasaki M. Increased water diffusion in cerebral white matter in Alzheimer's disease. Gerontology. 1997;43:343-351.
37. Braak H, Dell Tredici K, Schultz C, Braak E. Vulnerability of select neuronal types to Alzheimer's disease. Ann N Y Acad Sci. 2000;924:53-61.
38. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
39. Sivan AB. Benton Visual Retention Test Manual. 5th ed. San Antonio, Tex: Psychological Corp; 1992.
40. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test Manual. San Antonio, Tex: Psychological Corp; 1987.
41. Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio, Tex: Psychological Corp; 1981.
42. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
43. Efron B. The Jacknife, the Bootstrap, and Other Resampling Plans. Philadelphia, Pa: Society for Industrial and Applied Mathematics; 1982.
44. Peters A, Sethares C, Killiany RJ. Effects of age on the thickness of myelin sheaths in monkey primary visual cortex. J Comp Neurol. 2001;435:241-248.
45. England E, Brun A. Frontal lobe degeneration of non-Alzheimer type, IV: white matter changes. Arch Gerontol Geriatr. 1987;6:235-243.
46. Chia LS, Thomson JE, Moscarello MA. X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer's disease. Biochim BiophysActa. 1984;775:308-312.
47. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol. 1986;19:253-262.
48. Englund E, Brun A, Ailing C. White matter changes in dementia of Alzheimer's type: biochemical and neuropathological correlates. Brain. 1988;111:1425-1439.
49. Meier-Rouge W, Ulrich J, Bruhlmann M, Meier E. Age-related white matter atrophy in the human brain. Ann N Y Acad Sci. 1992;26:260-269.
50. Peters A, Rosene DL, Moss MB, et al. Neurobiological bases of age-related cognitive decline in the rhesus monkey. J Neuropathol Exp Neurol. 1996;55:861-874.
51. Tang Y, Nyengaard JR, Pakkenberg B, Gundersen HJ. Age-induced white matter changes in the human brain: a stereological investigation. Neurobiol Aging. 1997;18:609-615.
52. Seno H, Inagaki T, Yamamori C, Miyaoka T, Horiguchi J. Dementia of Alzheimer type with and without multiple lacunar infarctions: evaluation of white matter lesions. Neuropathology. 2000;20:204-209.
53. Bartzokis G, Cummings JL, Markham CH, et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging. 1999;17:213-222.
54. Albert M. Neuropsychological and neurophysiological changes in healthy adult humans across the age range. Neurobiol Aging. 1993;14;623-625.
55. Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol. 1987;21:530-539.
56. Haug H. Brain sizes, surfaces, and neuronal sizes of the cortex cerebri: a stereological investigation of man and his variability and a comparison with some mammals (primates, whales, marsupials, insectivores, and one elephant). Am J Anat. 1987;180:126-142.
57. Peters A, Morrison JH, Rosene DL, Hyman BT. Are neurons lost from the primate cerebral cortex during normal aging? Cereb Cortex. 1998;8:295-300.
58. Price JL, Ko AJ, Wade MJ, Tsou SK, McKeel DW, Morris JC. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol. 2001;58:1395-1402.
59. Regeur L, Jensen GB, Pakkenberg H, Evans SM, Pakkenberg B. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol Aging. 1994;15:347-352.
60. West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet. 1994;344:769-772.
61. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18:351-357.
62. Mackenzie IR. Senile plaques do not progressively accumulate with normal aging. Acta Neuropathol (Berl). 1994;87:520-525.
63. Torp R, Head E, Milgram NW, Hahn F, Ottersen OP, Cotman CW. Ultrastructural evidence of fibrillar β-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains. Neuroscience. 2000;96:495-506.
64. Kiuru S, Salonen O, Haltia M. Gelsolin-related spinal and cerebral amyloid angiopathy. Ann Neurol. 1999;45:305-311.
65. Garcia-Ladona FJ, Huss Y, Frey P, Ghandour MS. Oligodendrocytes express different isoforms of β-amyloid precursor protein in chemically defined cell culture conditions: in situ hybridization and imunocytochemical detection. J Neurosci Res. 1997;50:50-61.
66. Varadarajan S, Yatin S, Askenova M, Butterfield DA. Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol. 2000;130:184-208.
67. Chance B, Sies H, Boveris A. Hydrogen peroxide metabolism in mammalian organs. Physiol Rev, 1979;59:527-593.
68. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 1997;23:134-147.
69. Montine TJ, Markesbery WZ, Zackert W, Sanchez SC, Roberts LJ II, Morrow JD. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with ApoE genotype in Alzheimer's disease patients. Am J Pathol. 1999;155:863-868.
70. Gamblin TC, King ME, Kuret J, Berry RW, Binder LI. Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry. 2000;39:14203-14210.
71. Gao S, Hendrie HC, Hall KS, Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry. 1998;55:809-815.
72. Salat DH, Kaye JA, Janowsky JS. Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer's disease. Arch Neurol. 2001;58:1403-1408.
73. Kraemer HC, Yesavage JA, Taylor JL, Kupfer D. How can we learn about developmental processes from cross-sectional studies, or can we? Am J Psychiatry. 2000;157:163-171.
74. Schäbitz WR, Li F, Fisher M. The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke. 2000;31:1709-1714.
75. Schmidt R, Hayn M, Fazekas F, Kapeller P, Esterbauer H. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals: correlations with plasma concentrations of naturally occurring antioxidants. Stroke. 1996;27:2043-2047.
76. Thomas T. Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease. Neurobiol Aging. 2000;21:343-348.
77. Alafuzoff I, Helisalmi S, Heinonen EH, et al. Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's disease. Eur J Clin Pharmacol. 2000;55:815-819.